Articulate Labs

Articulate Labs

Other, 3060 Pegasus Park Dr, Dallas, Texas, 75247, United States, 1-10 Employees

articulatelabs.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 51********

Who is ARTICULATE LABS

Articulate Labs has developed wearable technology that turns everyday activity into on-the-go physical therapy and rehabilitation through muscle stimulation and machine learning. The firs...

Read More

map
  • 3060 Pegasus Park Dr, Dallas, Texas, 75247, United States Headquarters: 3060 Pegasus Park Dr, Dallas, Texas, 75247, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • Josh Rabinowitz CEO:   Josh Rabinowitz

industries-icon Industry: Other

SIC SIC Code: 3842 | NAICS Code: 541614 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ARTICULATE LABS

Articulate Labs Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Articulate Labs

Answer: Articulate Labs's headquarters are located at 3060 Pegasus Park Dr, Dallas, Texas, 75247, United States

Answer: Articulate Labs's phone number is 51********

Answer: Articulate Labs's official website is https://articulatelabs.com

Answer: Articulate Labs's revenue is $1 Million to $5 Million

Answer: Articulate Labs's SIC: 3842

Answer: Articulate Labs's NAICS: 541614

Answer: Articulate Labs has 1-10 employees

Answer: Articulate Labs is in Other

Answer: Articulate Labs contact info: Phone number: 51******** Website: https://articulatelabs.com

Answer: Articulate Labs has developed wearable technology that turns everyday activity into on-the-go physical therapy and rehabilitation through muscle stimulation and machine learning. The first target market for this technology is the $5B knee treatment market. Here, our device (KneeStim) will enable mobile quadriceps strengthening and re-education for the 14M+ seeking conservative, cost- and time-efficient knee treatment. Company status: * Working prototype * Feasibility study conducted * Four patents issued; two pending * Independent market validation with likely prescribers * Regulatory pathway established * Reimbursement codes identified This device has not yet been cleared by the FDA for marketing, and all above statements are prospective.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access